Researchers have launched a groundbreaking embryo-genome sequencing test called XGEN PGT-X™, which makes comprehensive genetic screening for IVF embryos affordable and accessible. This test, developed by GenEmbryomics and Genomic Prediction, can now be performed for under $500 per embryo, a significant reduction from previous costs that often reached thousands of dollars. It offers a complete genomic analysis, screening for over 3,200 disease-related genes, inherited conditions, and mutations, providing valuable insights into the potential health of future children.

For individuals considering IVF, this advancement could mean a more informed decision-making process. With XGEN PGT-X™, you can gain a clearer understanding of your embryos’ genetic health, potentially reducing the risk of passing on genetic disorders. This could lead to healthier pregnancies and children, as parents will be better equipped to make choices based on comprehensive genetic information. The test aims to provide a personalized IVF experience, allowing families to understand the health trajectory of their embryos like never before.

Currently, XGEN PGT-X™ is a new offering and is not yet FDA-approved or CE marked as a diagnostic device. It represents a shift towards more routine use of whole-genome sequencing in IVF but should be approached with caution. The test results are subject to biological limitations and should be interpreted by qualified clinicians alongside genetic counseling. This means while the test is promising, it is still in the early stages of clinical application.

If you’re considering IVF, it may be worth discussing the option of XGEN PGT-X™ with your fertility clinic. Ensure you seek out clinics that are offering this new service and inquire about how it could fit into your IVF journey.

Source: globenewswire.com